SEC Form 4 · accession 0001391609-17-000171
NuLife Sciences, Inc. · NULF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Clarke
Officer — Secretary
Period of report
Feb 28, 2017
Accepted (ET)
Jul 11, 2017 · 12:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001592603
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Feb 28, 2017 | S | 100,000 | $0.01 | D | 1,400,000 | D | |
| Common stockF2 | Feb 28, 2017 | S | 100,000 | $0.01 | D | 1,300,000 | D | |
| Common stockF3 | Feb 28, 2017 | S | 700,000 | $0.01 | D | 600,000 | D | |
| Common stockF4 | Feb 28, 2017 | S | 100,000 | $0.01 | D | — | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 28, 2017, according to that certain Stock Purchase Agreement, Sean Clarke, Secretary of the Company, sold 100,000 shares of Common Stock.
- F2On February 28, 2017, according to that certain Stock Purchase Agreement, Sean Clarke, Secretary of the Company, sold 100,000 shares of Common Stock.
- F3On February 28, 2017, according to that certain Stock Purchase Agreement, Sean Clarke, Secretary of the Company, sold 700,000 shares of Common Stock.
- F4On February 28, 2017, according to that certain Stock Purchase Agreement, Sean Clarke, Secretary of the Company, sold 100,000 shares of Common Stock.